Fermenta Biotech Limited (BOM:506414)
298.60
-0.75 (-0.25%)
At close: May 5, 2026
Fermenta Biotech Market Cap
Fermenta Biotech has a market cap or net worth of 8.87 billion as of May 6, 2026. Its market cap has increased by 9.38% in one year.
Market Cap
8.87B
Enterprise Value
9.42B
Revenue
5.44B
Ranking
n/a
PE Ratio
10.20
Stock Price
298.60
Market Cap Chart
Since July 31, 1998, Fermenta Biotech's market cap has increased from 335.80M to 8.87B, an increase of 2,540.74%. That is a compound annual growth rate of 12.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 8.87B | -13.42% |
| Dec 31, 2025 | 10.24B | -4.38% |
| Dec 31, 2024 | 10.71B | 129.56% |
| Dec 29, 2023 | 4.67B | -6.88% |
| Dec 30, 2022 | 5.01B | -40.13% |
| Dec 31, 2021 | 8.37B | -8.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shukra Pharmaceuticals | 14.02B |
| Fredun Pharmaceuticals | 13.85B |
| Lincoln Pharmaceuticals | 13.66B |
| Syncom Formulations (India) | 13.22B |
| Venus Remedies | 13.08B |
| TTK Healthcare | 12.82B |
| Wanbury | 8.79B |
| Bharat Parenterals | 8.61B |